Whitehawk Therapeutics Inc

WHWK

WHWKWhitehawk Therapeutics Inc US flag

NASDAQ Global Market

4.34

USD

+0.16

- -

214.62MMarket Cap

Profitability (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-124.58	-35.37	-41.54	-62.83	-18.63
Return on Capital (%)	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	91.23	88.47	88.36	89.36
EBITDA Margin (%)	-18.14	-3,695.6	-386.42	-294.67	-248.73	-1,600.01
Operating Margin (%)	-18.21	-3,706.1	-387.47	-295.36	-249.47	-1,601.12
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-24.83	-11,008.8	-397.69	-270.04	-245.13	-288.26
Profit Margin (%)	-24.84	-11,009	-397.69	-270.04	-245.13	-288.26
Net Income to Common Margin (%)	-31.89	-11,073.7	-397.69	-270.04	-245.13	-288.26
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	22.11	-3.4	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	10	1	2	1	1	- -
ST Debt	9	- -	- -	- -	- -	- -
LT Debt	1	- -	1	1	1	- -
Total Debt/EBITDA	-4.04	-0.02	-0.03	-0.02	-0.01	- -
Net Debt/EBITDA	-2.23	4.03	0.66	0.88	0.44	0.33
Total Debt/EBIT	-4.02	-0.02	-0.03	-0.02	-0.01	- -
Net Debt/EBIT	-2.23	4.02	0.66	0.87	0.44	0.33
EBITDA to Interest Expense	-3.12	-55.57	-255.64	-310.67	-419.66	- -
EBITDA-CapEx/Interest Expense	-3.12	-55.64	-257.57	-327.86	-430.4	- -
EBIT to Interest Expense	-3.13	-55.73	-256.33	-311.4	-420.91	- -
Interest Expense	1	1	- -	- -	- -	- -
Common Equity/Total Assets	-173.14	-90.36	-110.29	-203.11	-473.06	-234.2
Long-Term Debt/Equity (%)	- -	0.35	0.8	0.79	1.08	- -
Long-Term Debt/Capital (%)	-4.93	-0.33	-0.63	-0.31	-0.17	- -
Long-Term Debt/Total Assets (%)	5.85	0.3	0.69	0.63	0.8	- -
Total Debt/Equity (%)	-82.5	0.44	1.05	1.2	1.59	- -
Total Debt/Capital (%)	-45.91	-0.43	-0.82	-0.47	-0.25	- -
Total Debt/Total Assets (%)	54.48	0.38	0.9	0.96	1.18	- -
Net Debt to Equity	-45.66	-109.22	-24.64	-59.78	-54.63	-27.56
Net Debt/Capital (%)	-21.19	51.19	16.22	19.02	7.95	9.61
EBITDA	-3	-37	-59	-72	-65	-114
EBITDA-CapEx	-3	-37	-59	-76	-66	-115
Operating Income (Loss)	-3	-37	-59	-72	-65	-114

Liquidity (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.15	9.76	9.16	4.12	2.77	10.03
Current Ratio	0.62	9.9	9.56	4.72	3.59	10.26
Quick Ratio	0.62	9.76	9.26	4.33	3.11	10.03
CFO/Avg Current Liab	- -	-0.99	-2.91	-2.64	-2.74	-6.17
Common Equity/Total Assets	-173.14	-90.36	-110.29	-203.11	-473.06	-234.2
Long-Term Debt/Equity (%)	- -	0.35	0.8	0.79	1.08	- -
Long-Term Debt/Capital (%)	-4.93	-0.33	-0.63	-0.31	-0.17	- -
Long-Term Debt/Total Assets (%)	5.85	0.3	0.69	0.63	0.8	- -
Total Debt/Equity (%)	-82.5	0.44	1.05	1.2	1.59	- -
Total Debt/Capital (%)	-45.91	-0.43	-0.82	-0.47	-0.25	- -
Total Debt/Total Assets (%)	54.48	0.38	0.9	0.96	1.18	- -
CFO/Total Liabilities	-40.63	-104.27	-191.96	-219.12	-333.78	-671.07
CFO/CapEx	- -	-487.46	-111.8	-15.02	-36	-176.51
Altman's Z-Score	3.03	4.99	5.23	-2.36	-5.67	1.52

Working Capital (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	0.14	16.34	6.63	4.56	2.42
Days Sales Outstanding	- -	2,582.19	22.33	55.08	80.01	150.78
Inventory Turnover	- -	- -	1.43	0.68	0.52	0.29
Days Inventory Outstanding	- -	- -	254.41	538.47	708.39	1,275.34
Accounts Payable Turnover	- -	- -	0.64	1.57	0.47	-2.96
Accounts Payable Turnover Days	- -	- -	568.63	233.03	770.65	-123.35
Cash Conversion Cycle	- -	- -	-291.89	360.52	17.75	1,549.47
Inventory to Cash Days	- -	- -	-232.07	-483.39	-628.39	-1,124.56
Inventories	- -	- -	2	6	5	- -
Raw Materials	- -	- -	1	5	4	- -
Work In Process	- -	- -	- -	1	- -	- -
Finished Goods	- -	- -	1	- -	2	- -
Other Inventory	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	306	215	289	54	85	150
- Cash & Cash Equivalents	4	149	39	63	29	38
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
+ Total Debt	10	1	2	1	1	- -
Enterprise Value	312	67	118	-53	39	4
Total Capital	-22	-142	-202	-268	-332	-353
Total Debt/Capital (%)	-45.91	-0.43	-0.82	-0.47	-0.25	- -
Total Debt / EV	0.03	0.01	0.01	-0.02	0.02	- -
EV/Sales	22.29	67.12	7.75	- -	1.5	0.57
EV/EBITDA	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Diluted Market Cap	306	215	289	54	85	150
Diluted Enterprise Value	312	67	251	-7	58	112
EV per Share	14.98	7.52	5.24	- -	1.44	0.07
TTM Sales	14	1	15	24	26	7
TTM EBITDA	-3	-37	-59	-72	-65	-114
TTM Operating Income	-3	-37	-59	-72	-65	-114
TTM Cash Flow to Firm	-12	-22	-49	-59	-59	-97
TTM Free Cash Flow to Firm	-12	-22	-49	-55	-58	-97

Multiples (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-24.12	-9.63	-5.87	-0.98	-1.48	-1.55
EV/EBIT	- -	- -	- -	- -	- -	- -
Enterprise Value	312	67	118	-53	39	4
Low Price	6.3	14.31	11	1.9	1.21	1.39
EV/Sales	22.29	67.12	7.75	- -	1.5	0.57
EV/EBITDA	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-75.83	-2.05	-5.59	-2.91	-0.81	-6.36
Price/Earnings High	-161.71	-4.01	-9.43	-5.51	-1.53	-11.45
Price/Earnings Low	-29.4	-1.15	-4.09	-0.78	-0.51	-4.18
Price/Book Value	-9.4	-1.51	-1.42	-0.2	-0.26	-0.42
Price/Book Value Average	-10.39	-1.59	-1.67	-0.71	-0.16	-0.37
Price/Book Value High	-22.15	-3.11	-2.81	-1.35	-0.29	-0.67
Price/Book Value Low	-4.03	-0.89	-1.22	-0.19	-0.1	-0.24
Price/Tangible Book Value	-24.64	1.63	1.82	0.52	1.63	1.1
Price/Tangible Book Value Average	-27.23	1.71	2.14	1.82	0.99	0.96
Price/Tangible Book Value High	-58.08	3.35	3.6	3.44	1.85	1.73
Price/Tangible Book Value Low	-10.56	0.96	1.56	0.49	0.62	0.63
Price/Sales	21.88	215.5	18.98	2.23	3.29	20.96
Price/Sales Average	24.18	226.67	22.24	7.85	1.99	18.33
Price/Sales High	51.57	444.38	37.52	14.87	3.75	33
Price/Sales Low	9.38	127.69	16.27	2.1	1.26	12.04
Price/Cash Flow	-24.12	-9.61	-5.82	-0.91	-1.43	-1.54
Price/Cash Flow Average	-26.66	-10.11	-6.82	-3.2	-0.87	-1.34
Price/Cash Flow High	-56.85	-19.82	-11.5	-6.07	-1.63	-2.42
Price/Cash Flow Low	-10.34	-5.69	-4.99	-0.86	-0.55	-0.88
Price/Free Cash Flow Average	-26.66	-10.13	-6.88	-3.43	-0.89	-1.35
Price/Free Cash Flow High	-56.85	-19.86	-11.6	-6.5	-1.68	-2.43
Price/Free Cash Flow Low	-10.34	-5.71	-5.03	-0.92	-0.56	-0.89
EV/Sales Average	24.6	78.29	19.78	5.32	0.92	13.07
EV/Sales High	51.99	296	35.06	12.34	2.67	27.74
EV/Sales Low	9.79	- -	13.82	- -	0.19	6.78
EV/EBITDA Average	-135.58	-2.12	-5.12	-1.8	-0.37	-0.82
EV/EBITDA High	-286.55	-8.01	-9.07	-4.19	-1.07	-1.73
EV/EBITDA Low	-53.97	0.56	-3.58	0.15	-0.08	-0.42
EV/EBIT Average	-135.1	-2.11	-5.11	-1.8	-0.37	-0.82
EV/EBIT High	-285.54	-7.99	-9.05	-4.18	-1.07	-1.73
EV/EBIT Low	-53.78	0.56	-3.57	0.15	-0.08	-0.42
Last Price	14.7	24.15	12.83	2.02	3.16	2.42
High Price	34.65	49.8	25.36	13.45	3.6	3.81
Enterprise Value Average	344	78	301	129	24	93
Enterprise Value High	728	296	534	300	69	198
Enterprise Value Low	137	-21	210	-10	5	48

Profitability (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-124.58	-35.37	-41.54	-62.83	-18.63
Return on Capital (%)	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	91.23	88.47	88.36	89.36
EBITDA Margin (%)	-18.14	-3,695.6	-386.42	-294.67	-248.73	-1,600.01
Operating Margin (%)	-18.21	-3,706.1	-387.47	-295.36	-249.47	-1,601.12
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-24.83	-11,008.8	-397.69	-270.04	-245.13	-288.26
Profit Margin (%)	-24.84	-11,009	-397.69	-270.04	-245.13	-288.26
Net Income to Common Margin (%)	-31.89	-11,073.7	-397.69	-270.04	-245.13	-288.26
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	22.11	-3.4	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	10	1	2	1	1	- -
ST Debt	9	- -	- -	- -	- -	- -
LT Debt	1	- -	1	1	1	- -
Total Debt/EBITDA	-4.04	-0.02	-0.03	-0.02	-0.01	- -
Net Debt/EBITDA	-2.23	4.03	0.66	0.88	0.44	0.33
Total Debt/EBIT	-4.02	-0.02	-0.03	-0.02	-0.01	- -
Net Debt/EBIT	-2.23	4.02	0.66	0.87	0.44	0.33
EBITDA to Interest Expense	-3.12	-55.57	-255.64	-310.67	-419.66	- -
EBITDA-CapEx/Interest Expense	-3.12	-55.64	-257.57	-327.86	-430.4	- -
EBIT to Interest Expense	-3.13	-55.73	-256.33	-311.4	-420.91	- -
Interest Expense	1	1	- -	- -	- -	- -
Common Equity/Total Assets	-173.14	-90.36	-110.29	-203.11	-473.06	-234.2
Long-Term Debt/Equity (%)	- -	0.35	0.8	0.79	1.08	- -
Long-Term Debt/Capital (%)	-4.93	-0.33	-0.63	-0.31	-0.17	- -
Long-Term Debt/Total Assets (%)	5.85	0.3	0.69	0.63	0.8	- -
Total Debt/Equity (%)	-82.5	0.44	1.05	1.2	1.59	- -
Total Debt/Capital (%)	-45.91	-0.43	-0.82	-0.47	-0.25	- -
Total Debt/Total Assets (%)	54.48	0.38	0.9	0.96	1.18	- -
Net Debt to Equity	-45.66	-109.22	-24.64	-59.78	-54.63	-27.56
Net Debt/Capital (%)	-21.19	51.19	16.22	19.02	7.95	9.61
EBITDA	-3	-37	-59	-72	-65	-114
EBITDA-CapEx	-3	-37	-59	-76	-66	-115
Operating Income (Loss)	-3	-37	-59	-72	-65	-114

Liquidity (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.15	9.76	9.16	4.12	2.77	10.03
Current Ratio	0.62	9.9	9.56	4.72	3.59	10.26
Quick Ratio	0.62	9.76	9.26	4.33	3.11	10.03
CFO/Avg Current Liab	- -	-0.99	-2.91	-2.64	-2.74	-6.17
Common Equity/Total Assets	-173.14	-90.36	-110.29	-203.11	-473.06	-234.2
Long-Term Debt/Equity (%)	- -	0.35	0.8	0.79	1.08	- -
Long-Term Debt/Capital (%)	-4.93	-0.33	-0.63	-0.31	-0.17	- -
Long-Term Debt/Total Assets (%)	5.85	0.3	0.69	0.63	0.8	- -
Total Debt/Equity (%)	-82.5	0.44	1.05	1.2	1.59	- -
Total Debt/Capital (%)	-45.91	-0.43	-0.82	-0.47	-0.25	- -
Total Debt/Total Assets (%)	54.48	0.38	0.9	0.96	1.18	- -
CFO/Total Liabilities	-40.63	-104.27	-191.96	-219.12	-333.78	-671.07
CFO/CapEx	- -	-487.46	-111.8	-15.02	-36	-176.51
Altman's Z-Score	3.03	4.99	5.23	-2.36	-5.67	1.52

Working Capital (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	0.14	16.34	6.63	4.56	2.42
Days Sales Outstanding	- -	2,582.19	22.33	55.08	80.01	150.78
Inventory Turnover	- -	- -	1.43	0.68	0.52	0.29
Days Inventory Outstanding	- -	- -	254.41	538.47	708.39	1,275.34
Accounts Payable Turnover	- -	- -	0.64	1.57	0.47	-2.96
Accounts Payable Turnover Days	- -	- -	568.63	233.03	770.65	-123.35
Cash Conversion Cycle	- -	- -	-291.89	360.52	17.75	1,549.47
Inventory to Cash Days	- -	- -	-232.07	-483.39	-628.39	-1,124.56
Inventories	- -	- -	2	6	5	- -
Raw Materials	- -	- -	1	5	4	- -
Work In Process	- -	- -	- -	1	- -	- -
Finished Goods	- -	- -	1	- -	2	- -
Other Inventory	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	306	215	289	54	85	150
- Cash & Cash Equivalents	4	149	39	63	29	38
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
+ Total Debt	10	1	2	1	1	- -
Enterprise Value	312	67	118	-53	39	4
Total Capital	-22	-142	-202	-268	-332	-353
Total Debt/Capital (%)	-45.91	-0.43	-0.82	-0.47	-0.25	- -
Total Debt / EV	0.03	0.01	0.01	-0.02	0.02	- -
EV/Sales	22.29	67.12	7.75	- -	1.5	0.57
EV/EBITDA	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Diluted Market Cap	306	215	289	54	85	150
Diluted Enterprise Value	312	67	251	-7	58	112
EV per Share	14.98	7.52	5.24	- -	1.44	0.07
TTM Sales	14	1	15	24	26	7
TTM EBITDA	-3	-37	-59	-72	-65	-114
TTM Operating Income	-3	-37	-59	-72	-65	-114
TTM Cash Flow to Firm	-12	-22	-49	-59	-59	-97
TTM Free Cash Flow to Firm	-12	-22	-49	-55	-58	-97

Multiples (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-24.12	-9.63	-5.87	-0.98	-1.48	-1.55
EV/EBIT	- -	- -	- -	- -	- -	- -
Enterprise Value	312	67	118	-53	39	4
Low Price	6.3	14.31	11	1.9	1.21	1.39
EV/Sales	22.29	67.12	7.75	- -	1.5	0.57
EV/EBITDA	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-75.83	-2.05	-5.59	-2.91	-0.81	-6.36
Price/Earnings High	-161.71	-4.01	-9.43	-5.51	-1.53	-11.45
Price/Earnings Low	-29.4	-1.15	-4.09	-0.78	-0.51	-4.18
Price/Book Value	-9.4	-1.51	-1.42	-0.2	-0.26	-0.42
Price/Book Value Average	-10.39	-1.59	-1.67	-0.71	-0.16	-0.37
Price/Book Value High	-22.15	-3.11	-2.81	-1.35	-0.29	-0.67
Price/Book Value Low	-4.03	-0.89	-1.22	-0.19	-0.1	-0.24
Price/Tangible Book Value	-24.64	1.63	1.82	0.52	1.63	1.1
Price/Tangible Book Value Average	-27.23	1.71	2.14	1.82	0.99	0.96
Price/Tangible Book Value High	-58.08	3.35	3.6	3.44	1.85	1.73
Price/Tangible Book Value Low	-10.56	0.96	1.56	0.49	0.62	0.63
Price/Sales	21.88	215.5	18.98	2.23	3.29	20.96
Price/Sales Average	24.18	226.67	22.24	7.85	1.99	18.33
Price/Sales High	51.57	444.38	37.52	14.87	3.75	33
Price/Sales Low	9.38	127.69	16.27	2.1	1.26	12.04
Price/Cash Flow	-24.12	-9.61	-5.82	-0.91	-1.43	-1.54
Price/Cash Flow Average	-26.66	-10.11	-6.82	-3.2	-0.87	-1.34
Price/Cash Flow High	-56.85	-19.82	-11.5	-6.07	-1.63	-2.42
Price/Cash Flow Low	-10.34	-5.69	-4.99	-0.86	-0.55	-0.88
Price/Free Cash Flow Average	-26.66	-10.13	-6.88	-3.43	-0.89	-1.35
Price/Free Cash Flow High	-56.85	-19.86	-11.6	-6.5	-1.68	-2.43
Price/Free Cash Flow Low	-10.34	-5.71	-5.03	-0.92	-0.56	-0.89
EV/Sales Average	24.6	78.29	19.78	5.32	0.92	13.07
EV/Sales High	51.99	296	35.06	12.34	2.67	27.74
EV/Sales Low	9.79	- -	13.82	- -	0.19	6.78
EV/EBITDA Average	-135.58	-2.12	-5.12	-1.8	-0.37	-0.82
EV/EBITDA High	-286.55	-8.01	-9.07	-4.19	-1.07	-1.73
EV/EBITDA Low	-53.97	0.56	-3.58	0.15	-0.08	-0.42
EV/EBIT Average	-135.1	-2.11	-5.11	-1.8	-0.37	-0.82
EV/EBIT High	-285.54	-7.99	-9.05	-4.18	-1.07	-1.73
EV/EBIT Low	-53.78	0.56	-3.57	0.15	-0.08	-0.42
Last Price	14.7	24.15	12.83	2.02	3.16	2.42
High Price	34.65	49.8	25.36	13.45	3.6	3.81
Enterprise Value Average	344	78	301	129	24	93
Enterprise Value High	728	296	534	300	69	198
Enterprise Value Low	137	-21	210	-10	5	48

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	21	21	24	25	25	47
Diluted Weighted Avg Shares	21	9	23	27	27	62
Basic Weighted Avg Shares	21	9	23	27	27	62
Revenue per Share	0.67	0.11	0.68	0.9	0.96	0.12
EBITDA per Share	-0.12	-4.14	-2.61	-2.67	-2.39	-1.85
Operating Income per Share	-0.12	-4.15	-2.62	-2.67	-2.4	-1.85
Basic EPS, GAAP	-0.21	-12.41	-2.69	-2.44	-2.36	-0.33
Basic EPS from Cont Ops	-0.17	-12.34	-2.69	-2.44	-2.36	-0.33
Diluted EPS, GAAP	-0.21	-12.41	-2.69	-2.44	-2.36	-0.33
Diluted EPS from Cont Ops	-0.17	-12.34	-2.69	-2.44	-2.36	-0.33
Dividend per Share	- -	0.49	- -	- -	- -	- -
Cash Flow per Share	-0.61	-2.51	-2.21	-2.22	-2.2	-1.57
Free Cash Flow per Basic Share	-0.61	-2.52	-2.22	-2.36	-2.26	-1.58
Cash & Equivalents per Share	0.21	16.7	7.67	4.04	1.75	2.35
Book Value per Share	-1.56	-15.99	-9.03	-9.99	-12.31	-5.71
Tangible Book Value per Share	-0.6	14.86	7.04	3.91	1.94	2.2

Whitehawk Therapeutics Inc

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)